Marek Dudziński

438 total citations
11 papers, 50 citations indexed

About

Marek Dudziński is a scholar working on Hematology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Marek Dudziński has authored 11 papers receiving a total of 50 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Hematology, 3 papers in Genetics and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Marek Dudziński's work include Acute Lymphoblastic Leukemia research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Marek Dudziński is often cited by papers focused on Acute Lymphoblastic Leukemia research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Marek Dudziński collaborates with scholars based in Poland, United States and Italy. Marek Dudziński's co-authors include Marek Hus, Sławomira Kyrcz‐Krzemień, Grzegorz Helbig, Stanisława Bazan‐Socha, Michał J. Dąbrowski, Grzegorz Basak, Michał Nowicki, Wojciech Homenda, Andrzej Pluta and Tomasz Sacha and has published in prestigious journals such as Blood, Frontiers in Oncology and Journal of Clinical Medicine.

In The Last Decade

Marek Dudziński

9 papers receiving 49 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Dudziński Poland 4 28 21 19 17 7 11 50
Rita Paschal United States 3 14 0.5× 21 1.0× 14 0.7× 10 0.6× 3 0.4× 5 47
Jonathan T. L. Cheah United States 6 34 1.2× 20 1.0× 8 0.4× 11 0.6× 2 0.3× 10 68
George Sfikas Greece 4 26 0.9× 32 1.5× 36 1.9× 20 1.2× 2 0.3× 7 74
Teresa Ruíz Spain 4 26 0.9× 22 1.0× 15 0.8× 4 0.2× 19 2.7× 4 51
Soumaya El Mahou France 4 36 1.3× 6 0.3× 10 0.5× 14 0.8× 6 0.9× 8 61
Koshy Thomas India 3 15 0.5× 23 1.1× 7 0.4× 8 0.5× 14 2.0× 6 38
Amy Shepherd United Kingdom 4 20 0.7× 12 0.6× 32 1.7× 15 0.9× 3 0.4× 9 85
Marco Bobbo Italy 6 13 0.5× 21 1.0× 4 0.2× 12 0.7× 7 1.0× 21 81
C. Comarmond France 3 22 0.8× 23 1.1× 9 0.5× 4 0.2× 10 1.4× 8 50
Sílvia Papasidero Argentina 5 73 2.6× 29 1.4× 13 0.7× 6 0.4× 21 3.0× 17 87

Countries citing papers authored by Marek Dudziński

Since Specialization
Citations

This map shows the geographic impact of Marek Dudziński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Dudziński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Dudziński more than expected).

Fields of papers citing papers by Marek Dudziński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Dudziński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Dudziński. The network helps show where Marek Dudziński may publish in the future.

Co-authorship network of co-authors of Marek Dudziński

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Dudziński. A scholar is included among the top collaborators of Marek Dudziński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Dudziński. Marek Dudziński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Helbig, Grzegorz, Marta Sobas, Jarosław Piszcz, et al.. (2025). A multi-center study of a machine learning algorithm for identifying undiagnosed patients with myelodysplastic syndrome based on complete blood count data. Blood. 146(Supplement 1). 5629–5629.
2.
Dudziński, Marek, et al.. (2023). Supporting the Diagnosis of Fabry Disease Using a Natural Language Processing-Based Approach. Journal of Clinical Medicine. 12(10). 3599–3599. 12 indexed citations
3.
Deręgowska, Anna, Marcin M. Machnicki, Marek Dudziński, et al.. (2023). The interplay between telomeric complex members and BCR::ABL1 oncogenic tyrosine kinase in the maintenance of telomere length in chronic myeloid leukemia. Journal of Cancer Research and Clinical Oncology. 149(10). 7103–7112. 1 indexed citations
4.
Canzian, Federico, Joanna Góra‐Tybor, Daniele Campa, et al.. (2022). Impact of genetic polymorphisms of drug transporters ABCB1 and ABCG2 and regulators of xenobiotic transport and metabolism PXR and CAR on clinical efficacy of dasatinib in chronic myeloid leukemia. Frontiers in Oncology. 12. 952640–952640. 3 indexed citations
5.
Markiewicz, Mirosław, et al.. (2021). Multifocal Pyoderma Gangrenosum with an Underlying Hemophagocytic Lymphohistiocytosis: Case Report and the Review of the Literature. Dermatology and Therapy. 11(4). 1217–1237. 1 indexed citations
6.
Warzocha, Krzysztof, Wojciech Homenda, Andrzej Pluta, et al.. (2019). Ruksolitynib w terapii chorych na mielofibrozę — pytania i odpowiedzi. Via Medica Journals. 9(4). 269–284. 1 indexed citations
7.
Długosz‐Danecka, Monika, Wojciech Jurczak, Marta Morawska, et al.. (2018). Efficacy and safety of the obinutuzumab-chlorambucil combination in the frontline treatment of elderly CLL patients with comorbidities – Polish Adult Leukemia Group (PALG) real-life analysis. Polskie Archiwum Medycyny Wewnętrznej. 128(7-8). 421–426. 4 indexed citations
8.
9.
Sacha, Tomasz, Joanna Góra‐Tybor, Olga Grzybowska‐Izydorczyk, et al.. (2016). Imatinib Generics in Treatment of Chronic Myeloid Leukemia; A Prospective Observation in Large Cohort of Patients from Polish (PALG) Imatinib Generics Registry. Blood. 128(22). 629–629. 2 indexed citations
10.
Helbig, Grzegorz, et al.. (2011). Imatinib mesylate may induce long-term clinical response in FIP1L1-PDGFRα-negative hypereosinophilic syndrome. Medical Oncology. 29(2). 1073–1076. 25 indexed citations
11.
Hołowiecki, Jerzy, Sebastian Giebel, Beata Stella‐Hołowiecka, et al.. (2009). Liposomal cytarabine in advanced-stage acute lymphoblastic leukemia and aggressive lymphoma with central nervous system involvement: experience of The Polish Acute Leukemia Group. Leukemia & lymphoma. 50(3). 478–480. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rita Paschal Breakdown of academic impact, for papers by Jonathan T. L. Cheah Breakdown of academic impact, for papers by George Sfikas Breakdown of academic impact, for papers by Teresa Ruíz Breakdown of academic impact, for papers by Soumaya El Mahou Breakdown of academic impact, for papers by Koshy Thomas Breakdown of academic impact, for papers by Amy Shepherd Breakdown of academic impact, for papers by Marco Bobbo Breakdown of academic impact, for papers by C. Comarmond Breakdown of academic impact, for papers by Sílvia Papasidero
Rankless by CCL
2026